Loss of ARID1A expression in NSCLC was associated with poorly differentiated histology, smoking status, lymphatic invasion, distant metastasis, higher TNM stage, and predicted reduced overall survival [118,119,123,124,125]. Here, ARID1A is linked to non-small cell lung carcinoma.